Janus Henderson Global Life Sciences Fund
Registrant
Janus Investment Fund
Class tickers
JAGLX
JFNAX
JFNCX
JFNIX
JFNNX
JFNSX
JNGLX
Net Assets
$5,807,758,449
Holdings
74
Latest Report
Jun 30, 2026
Net Assets Over Time
Holdings · 74
Export CSV
Portfolio coverage: 74 of
107 reported positions.
Showing 1–50
of 74 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Eli Lilly & Co. | LLY | 455,585 | $546,442,317 | 9.41% | Long | EC | |
| Johnson & Johnson | JNJ | 1,621,482 | $411,807,784 | 7.09% | Long | EC | |
| AbbVie, Inc. | ABBV | 1,077,025 | $271,022,571 | 4.67% | Long | EC | |
| UnitedHealth Group, Inc. | UNH | 634,279 | $263,625,381 | 4.54% | Long | EC | |
| Revolution Medicines, Inc. | RVMD | 936,558 | $175,398,582 | 3.02% | Long | EC | |
| Argenx SE | ARGX | 164,585 | $152,697,025 | 2.63% | Long | EC | |
| Novartis AG | NVS | 949,726 | $148,841,059 | 2.56% | Long | EC | |
| Thermo Fisher Scientific, Inc. | TMO | 270,088 | $135,411,320 | 2.33% | Long | EC | |
| Praxis Precision Medicines, Inc. | PRAX | 379,352 | $127,003,256 | 2.19% | Long | EC | |
| Bridgebio Pharma, Inc. | BBIO | 1,590,382 | $118,451,651 | 2.04% | Long | EC | |
| CVS Health Corp. | CVS | 1,132,543 | $117,161,573 | 2.02% | Long | EC | |
| Intuitive Surgical, Inc. | ISRG | 283,906 | $112,903,738 | 1.94% | Long | EC | |
| Merck & Co., Inc. | MRK | 847,026 | $108,842,841 | 1.87% | Long | EC | |
| Abbott Laboratories | ABT | 1,193,133 | $108,264,888 | 1.86% | Long | EC | |
| Vertex Pharmaceuticals, Inc. | VRTX | 197,846 | $98,276,044 | 1.69% | Long | EC | |
| Danaher Corp. | DHR | 502,471 | $95,710,676 | 1.65% | Long | EC | |
| Amgen, Inc. | AMGN | 262,742 | $95,144,133 | 1.64% | Long | EC | |
| Stryker Corp. | SYK | 260,477 | $82,008,579 | 1.41% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 995,577 | $81,209,216 | 1.40% | Long | EC | |
| Gilead Sciences, Inc. | GILD | 637,400 | $80,529,116 | 1.39% | Long | EC | |
| Travere Therapeutics, Inc. | TVTX | 1,413,117 | $80,279,177 | 1.38% | Long | EC | |
| Madrigal Pharmaceuticals, Inc. | MDGL | 145,364 | $78,053,200 | 1.34% | Long | EC | |
| HCA Healthcare, Inc. | HCA | 188,403 | $73,456,446 | 1.26% | Long | EC | |
| Mirum Pharmaceuticals, Inc. | MIRM | 558,993 | $65,441,311 | 1.13% | Long | EC | |
| Boston Scientific Corp. | BSX | 1,530,844 | $65,336,422 | 1.12% | Long | EC | |
|
Teva Pharmaceutical Industries Ltd.
|
881624209 | 1,883,103 | $63,799,530 | 1.10% | Long | EC | |
| United Therapeutics Corp. | UTHR | 114,790 | $62,196,666 | 1.07% | Long | EC | |
| Elevance Health, Inc. | ELV | 156,583 | $60,555,344 | 1.04% | Long | EC | |
| Globus Medical, Inc. | GMED | 744,421 | $58,816,703 | 1.01% | Long | EC | |
| Lantheus Holdings, Inc. | LNTH | 508,445 | $56,406,888 | 0.97% | Long | EC | |
| McKesson Corp. | MCK | 73,813 | $55,773,103 | 0.96% | Long | EC | |
| Vaxcyte, Inc. | PCVX | 942,493 | $54,787,118 | 0.94% | Long | EC | |
| Dyne Therapeutics, Inc. | DYN | 2,272,649 | $50,475,534 | 0.87% | Long | EC | |
| Edwards Lifesciences Corp. | EW | 500,885 | $45,310,057 | 0.78% | Long | EC | |
| Cencora, Inc. | COR | 123,277 | $34,884,925 | 0.60% | Long | EC | |
| Medline, Inc. | MDLN | 851,191 | $33,570,973 | 0.58% | Long | EC | |
| Definium Therapeutics, Inc. | DFTX | 710,241 | $33,409,737 | 0.58% | Long | EC | |
| Insmed, Inc. | INSM | 305,544 | $32,577,101 | 0.56% | Long | EC | |
| Dexcom, Inc. | DXCM | 462,075 | $31,120,751 | 0.54% | Long | EC | |
| Structure Therapeutics, Inc. | GPCR | 549,353 | $29,483,776 | 0.51% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 328,592 | $29,172,398 | 0.50% | Long | EC | |
| Ideaya Biosciences, Inc. | IDYA | 757,659 | $28,237,951 | 0.49% | Long | EC | |
| Glaukos Corp. | GKOS | 196,973 | $27,528,946 | 0.47% | Long | EC | |
|
Apogee Therapeutics, Inc.
|
03770N101 | 207,385 | $27,526,211 | 0.47% | Long | EC | |
| Edgewise Therapeutics, Inc. | EWTX | 677,076 | $27,509,598 | 0.47% | Long | EC | |
| Becton Dickinson & Co. | BDX | 175,886 | $26,616,828 | 0.46% | Long | EC | |
| Abivax SA | ABVX | 179,100 | $23,866,866 | 0.41% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 134,953 | $22,744,304 | 0.39% | Long | EC | |
| Tarsus Pharmaceuticals, Inc. | TARS | 346,737 | $21,823,627 | 0.38% | Long | EC | |
| Centene Corp. | CNC | 330,456 | $21,211,971 | 0.37% | Long | EC |
Showing the top 50 of 74 holdings. Create a free account to see every holding and download the CSV.